Eris Oaknet Healthcare Pvt Ltd transfers dermatalogy trademarks to Eris Lifesciences Ltd

Eris Oaknet Healthcare Private Limited, a wholly owned subsidiary of Eris Lifesciences Limited, has transferred to the Company all the dermatology trademarks that had been previously acquired from Glenmark Pharmaceuticals Limited and reported vide our disclosure dated January 17, 2023. The consideration for this intra group transfer is ~Rs.339.68 Crores.

The transfer of such trademarks is in furtherance of the previous disclosure dated May 17, 2023, bringing out our commitment to achieve the operational integration of the businesses of Eris Oaknet Healthcare Private Limited with the Company.

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 688.70 as compared to the previous close of Rs. 697.85. The total number of shares traded during the day was 5066 in over 574 trades.

The stock hit an intraday high of Rs. 708.60 and intraday low of 683.20. The net turnover during the day was Rs. 3506451.00.

Source : Equity Bulls

Keywords

ErisLifesciences INE406M01024 ErisOaknetHealthcare DermatologyTrademarks Transfer